"I have it just like you do": voices of HIV-negative partners in serodifferent relationships receiving primary care at a public clinic in San Francisco

AIDS Care. 2015;27(3):401-8. doi: 10.1080/09540121.2014.964659. Epub 2014 Oct 14.

Abstract

HIV transmission among serodifferent couples has a significant impact on incidence of HIV worldwide. Antiretroviral interventions (i.e., preexposure prophylaxis, post-exposure prophylaxis, and treatment as prevention) are important aspects of comprehensive prevention and care for serodifferent couples. In this study, HIV-negative members of serodifferent couples were interviewed using open-ended questions to explore their health-care needs, perceptions of clinic-based prevention services, and experience of having an HIV-infected partner. Analysis of interviews with 10 HIV-negative partners revealed the following themes: (1) health needs during joint medical visits; (2) sexual risk reduction strategies; (3) relationship dynamics; and (4) strategies for coping. This study elucidated relationship, health and health care factors that might affect development and implementation of clinic-based prevention interventions for HIV serodifferent couples. The findings point to possible relationship-centered recommendations for health-care providers who serve HIV-affected couples in clinical settings.

Keywords: HIV infection prevention and control; HIV serodiscordant; HIV seronegativity; sexual partners.

MeSH terms

  • Adaptation, Psychological
  • Adult
  • Ambulatory Care Facilities*
  • Anti-HIV Agents / therapeutic use*
  • Female
  • HIV Infections / epidemiology
  • HIV Infections / prevention & control*
  • HIV Infections / transmission
  • HIV Seronegativity*
  • HIV Seropositivity / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Post-Exposure Prophylaxis* / methods
  • Primary Health Care* / statistics & numerical data
  • Retrospective Studies
  • Risk Reduction Behavior
  • San Francisco / epidemiology
  • Sexual Behavior
  • Sexual Partners*
  • Surveys and Questionnaires

Substances

  • Anti-HIV Agents